Intercure Ltd 's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the fourth quarter 2025 to a ratio of 1.95, above the company average. This is a clear sign of healthy business climate in the Major Pharmaceutical Preparations industry and improving liquidity at their respective customers, during the fourth quarter 2025. Average receivable collection period, for the Intercure Ltd in Dec 31 2025 quarter, has decreased to 187 days, compared to 640 days, in the 0 quarter.

If we take a look into Healthcare sector 564 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Dec 31 2025 from 0 to 3773.

What is Receivable Turnover Ratio?
What is Intercure Ltd Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

INCR Receivables Turnover Ratio	(Dec 31 2025) IV. Quarter	0 III. Quarter	0 II. Quarter	0 I. Quarter	(Dec 31 2024) IV. Quarter
Y / Y Receivable Change	276.53 %	276.53 %	276.53 %	276.53 %	-73.88 %
Y / Y Revenue Change	318.38 %	-	-	-	-33.18 %
Receivable Turnover Ratio (TTM)	1.95	0.57	0.74	1.04	1.75
INCR's Total Ranking	# 3773	# 0	#	#	#
Accounts Receivable average collection period days	187	640	496	352	208
Seq. Receivable Change	0 %	0 %	0 %	276.53 %	0 %
Seq. Revenue Change	-	-	-	-	-

Receivable Turnover Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 192
Healthcare Sector	# 565
Overall Market	# 3773

Receivable Turnover Ratio Statistics
High	Average	Low
2.3	1.51	0.94
(Dec 31 2021)		(Dec 31 2024)

INCR Company Profile • Back to INCR Efficiency Comparisons • Compare INCR Receivables Turnover Ratio to its Competitors

Financial Statements
Intercure Ltd 's Accounts Receivable	$ 139 Millions	Visit INCR's Balance sheet
Intercure Ltd 's Sales TTM	$ 270 Millions	Visit INCR's Income Statement
Sources of INCR's Revenues		Visit INCR's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
INCR's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
INCR's Growth Rates	INCR's Roa	INCR's Inventory Turnover Ratio	INCR's Dividend Comparisons
INCR's Profitability Ratios	INCR's Roi	INCR's Asset Turnover Ratio	INCR's Dividend Growth
INCR's Valuation Ratios	INCR's Roe	INCR's Financial Strength Ratios	INCR's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Dec 31 2025, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Dec 31 2025	Receivable at quarter ending Dec 31 2025
Champions Oncology Inc	5.33	$ 57.944 Millions	$ 10.870 Millions
Korro Bio Inc	5.32	$ 6.392 Millions	$ 1.201 Millions
West Pharmaceutical Services Inc	5.29	$ 3,074.000 Millions	$ 581.350 Millions
Ligand Pharmaceuticals Incorporated	5.25	$ 268.087 Millions	$ 51.023 Millions
Verrica Pharmaceuticals Inc	5.24	$ 35.577 Millions	$ 6.788 Millions
Invivyd Inc	5.21	$ 53.426 Millions	$ 10.258 Millions
Staar Surgical Co	5.19	$ 239.442 Millions	$ 46.140 Millions
Exagen Inc	5.17	$ 65.799 Millions	$ 12.737 Millions
Zai Lab Limited	5.16	$ 460.156 Millions	$ 89.137 Millions
Vsee Health Inc	5.14	$ 12.448 Millions	$ 2.422 Millions
The Cooper Companies Inc	5.14	$ 4,151.100 Millions	$ 807.800 Millions
Carlsmed Inc	5.13	$ 50.150 Millions	$ 9.784 Millions
Xtant Medical Holdings Inc	5.12	$ 133.273 Millions	$ 26.052 Millions
Zimmer Biomet Holdings Inc	5.11	$ 8,231.500 Millions	$ 1,611.850 Millions
Concord Medical Services Holdings Ltd	5.11	$ 65.852 Millions	$ 12.899 Millions
Enovis Corp	5.09	$ 2,245.597 Millions	$ 440.968 Millions
Emmaus Life Sciences Inc	5.09	$ 12.166 Millions	$ 2.390 Millions
Amphastar Pharmaceuticals Inc	5.07	$ 719.887 Millions	$ 141.997 Millions
Casi Pharmaceuticals inc	5.06	$ 20.712 Millions	$ 4.092 Millions
Mdxhealth Sa	5.04	$ 107.875 Millions	$ 21.416 Millions
Rxsight Inc	5.03	$ 134.009 Millions	$ 26.638 Millions
Pfizer Inc	5.00	$ 62,579.000 Millions	$ 12,514.250 Millions
Opus Genetics Inc	4.99	$ 14.196 Millions	$ 2.847 Millions
Agilent Technologies inc	4.94	$ 7,065.000 Millions	$ 1,430.500 Millions
Progyny Inc	4.93	$ 1,288.484 Millions	$ 261.096 Millions
Fate Therapeutics Inc	4.92	$ 6.646 Millions	$ 1.350 Millions
Renovorx Inc	4.92	$ 1.123 Millions	$ 0.228 Millions
Pacific Biosciences Of California Inc	4.92	$ 159.780 Millions	$ 32.492 Millions
Privia Health Group Inc	4.90	$ 2,122.842 Millions	$ 433.166 Millions
Geron Corporation	4.89	$ 183.623 Millions	$ 37.557 Millions

Date modified: 2026-07-07T11:48:09+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.